Partnerships & Mergers

The agreement includes a USD135 million upfront payment to Sino Biopharmaceutical for worldwide rights, with up to USD1.39 billion in potential milestone payments based on development, regulatory approvals, and sales.

The formal signing ceremony brought together key stakeholders from both organizations, with Dr. Hanan Al Suwaidi representing Dubai Health and Prosun Niyogi signing on behalf of Johnson & Johnson MedTech, while Dr. Tarek Fathey attended as a witness to this landmark healthcare partnership.

The partnership will also support digital transformation, institutional capacity-building, and integrated health systems that promote sustainability and national ownership.

Each year, approximately 20,000 Ugandan patients travel to India seeking specialized cancer care unavailable at home.

EHS has become the first public health system in the UAE to implement a multi-agentic AI clinical intelligence platform.

Under the renewed agreement, Bora will provide end-to-end manufacturing services for more than 20 commercial GSK product lines.

The partnership seeks to create a more connected, innovation-driven healthcare landscape that aligns with the UAE’s vision for building a diversified, knowledge-based economy.

This initiative aligns with the Universal Health Coverage (UHC) agenda and seeks to transform regional facilities into dependable referral hubs that bring advanced cancer care closer to communities across the country.

The curriculum gives healthcare professionals the tools they need to balance clinical excellence with strategic business thinking, preparing them to tackle both current challenges and future opportunities.

At the heart of this collaboration sits Ribo’s GalSTAR platform, a specialized system designed to help develop RNA interference therapeutics that target disease-causing genes in liver conditions.